Pharmacological inhibition of the Jak-Stat pathway showed promising results in murine models of psoriasis reducing disease pathology, keratinocyte-activation, and proinflammatory cytokine levels (95, 98, 114). This evidence concerns the gene SOAT1 and psoriasis.